Cervical cancer advances give hope to poor

LONDON (Reuters) - New screening tests and effective vaccines from Merck & Co and GlaxoSmithKline make tackling cervical cancer in poor countries a real possibility for the first time, researchers said on Thursday.

Read The Full Story

Share: Digg - del.icio.us - Stumble It - News Vine - buzz-it

Source: Reuters Published: Thursday 28th of August 2008

Members: Save This Story